# Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation

> **NCT01157780** · NA · UNKNOWN · sponsor: **University of Tennessee** · enrollment: 100 (estimated)

## Conditions studied

- Parenteral Nutrition Associated Liver Disease

## Interventions

- **DRUG:** Lovaza (fish oil)

## Key facts

- **NCT ID:** NCT01157780
- **Lead sponsor:** University of Tennessee
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01157780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01157780, "Parenteral Nutrition Associated Liver Disease: Early Markers and Therapy Wih Enteral Omega-3 Supplementation". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01157780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*